Looker Benjamin 4

Accession 0001628280-26-002925

CIK 0001434868other

Filed

Jan 20, 7:00 PM ET

Accepted

Jan 21, 5:17 PM ET

Size

19.9 KB

Accession

0001628280-26-002925

AI-generated summary of this filing

Updated Jan 21, 2026

Esperion (ESPR) General Counsel Benjamin Looker Sells 1,689 Shares

What Happened

Benjamin Looker, General Counsel of Esperion Therapeutics (ESPR), sold 1,689 shares on January 20, 2026 at $2.88 per share for proceeds of $4,868. The filing indicates the sale was an open market or private sale and the shares were disposed to satisfy a tax obligation on vested restricted stock units (RSUs).

Key Details

Transaction date and price: 2026-01-20, 1,689 shares at $2.88 each.
Total proceeds: $4,868.
Reason/footnote: Sale made to satisfy tax withholding on vested RSUs (footnote F1).
Filing date: 2026-01-21; filing appears timely (no late filing indicated).
Shares owned after transaction: Not specified in the provided summary of the filing.

Context

This was a sale to cover tax obligations related to vested RSUs, a common and routine reason for insider sales (tax withholding), and not necessarily a signal of negative views on the company. No options were exercised and no 10b5-1 plan or other special trading arrangement was reported in the provided details.

Form 4

Period: 2026-01-20

General Counsel

Transactions

Footnotes (1)

[F1]Shares were sold to satisfy tax obligation on vested shares of restricted stock units.

Signature

/s/ Sheldon L. Koenig, by power of attorney|2026-01-21

2 files

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother